Utility of Blood Cultures in Pneumonia



      Blood cultures are of limited utility in nonsevere community-acquired pneumonia, though routinely recommended for severe community-acquired pneumonia or health care-associated pneumonia due to perceived greater bacteremia risk, particularly with multidrug-resistant organisms. The utility of this practice is unknown.


      In this observational cohort study, we abstracted data from medical records for consecutive hospitalizations for pneumonia by adults to an academic medical center from 2014-2015. The primary outcomes included bacteremia, multidrug-resistant organism bacteremia, and appropriate management changes attributed to culture results, stratified by pneumonia classification (nonsevere community-acquired pneumonia, severe community-acquired pneumonia, or health care-associated pneumonia) and likelihood the bacteremia was due to pneumonia vs another infection. We assessed the diagnostic test performance of one or more guideline-defined risk factors for bacteremia in nonsevere community-acquired pneumonia, for whom cultures are routinely recommended.


      Of 456 pneumonia hospitalizations, 30 (6.6%) had bacteremia, with a greater incidence in severe community-acquired pneumonia (14.7%) than nonsevere community-acquired pneumonia (7.8%) and health care-associated pneumonia (6.6%; P = .12). Seventeen bacteremia cases were likely due to pneumonia (3.7%). Only 2 (0.4%) had multidrug-resistant organisms (both health care-associated pneumonia), one of whom was due to pneumonia. Appropriate management changes occurred in 8 cases (1.8%; 7 de-escalation and 1 escalation of antibiotics); only 1 with bacteremia likely due to pneumonia (de-escalation). The one case of appropriate antibiotic escalation occurred in a patient with vancomycin-resistant Enterococcus unrelated to pneumonia. Having one or more guideline-defined risk factors did not identify bacteremia in nonsevere community-acquired pneumonia (positive likelihood ratio, 1.10; 95% confidence interval, 0.61-1.99).


      Routine blood cultures in pneumonia have extremely low yield and utility irrespective of severity and risk.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mandell L.A.
        • Wunderink R.G.
        • Anzueto A.
        • et al.
        Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
        Clin Infect Dis. 2007; 44: S27-S72
        • American Thoracic Society, Infectious Diseases Society of America
        Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.
        Am J Respir Crit Care Med. 2005; 171: 388-416
        • Fee C.
        • Weber E.
        • Sharpe B.A.
        • Nguy M.
        • Quon T.
        • Bookwalter T.
        JCAHO/CMS core measures for community-acquired pneumonia.
        Ann Emerg Med. 2006; 47 (author reply 506): 505
        • Fee C.
        • Weber E.J.
        • Sharpe B.A.
        • Quon T.
        When is a scarlet letter really a red badge of courage?: the paradox of percentage of pneumonia patients receiving antibiotics within 4 hours in accordance withJCAHO and CMS core measures.
        Ann Emerg Med. 2007; 50: 205-206
        • Nicks B.A.
        • Manthey D.E.
        • Fitch M.T.
        The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians.
        Acad Emerg Med. 2009; 16: 184-187
        • Makam A.N.
        • Auerbach A.D.
        • Steinman M.A.
        Blood culture use in the emergency department in patients hospitalized for community-acquired pneumonia.
        JAMA Intern Med. 2014; 174: 803-806
        • Makam A.N.
        • Auerbach A.D.
        • Steinman M.A.
        Blood culture use in the emergency department in patients hospitalized with respiratory symptoms due to a nonpneumonia illness.
        J Hosp Med. 2014; 9: 521-524
        • Afshar N.
        • Tabas J.
        • Afshar K.
        • Silbergleit R.
        Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review.
        J Hosp Med. 2009; 4: 112-123
        • Chalasani N.P.
        • Valdecanas M.A.
        • Gopal A.K.
        • McGowan Jr., J.E.
        • Jurado R.L.
        Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks.
        Chest. 1995; 108: 932-936
        • Campbell S.G.
        • Marrie T.J.
        • Anstey R.
        • Ackroyd-Stolarz S.
        • Dickinson G.
        Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department.
        Emerg Med J. 2003; 20: 521-523
        • van Werkhoven C.H.
        • Huijts S.M.
        • Postma D.F.
        • Oosterheert J.J.
        • Bonten M.J.
        Predictors of bacteraemia in patients with suspected community-acquired pneumonia.
        PLoS One. 2015; 10e0143817
        • Metersky M.L.
        • Ma A.
        • Bratzler D.W.
        • Houck P.M.
        Predicting bacteremia in patients with community-acquired pneumonia.
        Am J Respir Crit Care Med. 2004; 169: 342-347
        • Shorr A.F.
        • Zilberberg M.D.
        • Reichley R.
        • et al.
        Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.
        Clin Infect Dis. 2012; 54: 193-198
        • El-Solh A.A.
        • Sikka P.
        • Ramadan F.
        • Davies J.
        Etiology of severe pneumonia in the very elderly.
        Am J Respir Crit Care Med. 2001; 163: 645-651
        • Chalmers J.D.
        • Rother C.
        • Salih W.
        • Ewig S.
        Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.
        Clin Infect Dis. 2014; 58: 330-339
        • Lindenauer P.K.
        • Lagu T.
        • Shieh M.S.
        • Pekow P.S.
        • Rothberg M.B.
        Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009.
        JAMA. 2012; 307: 1405-1413
        • Magiorakos A.P.
        • Srinivasan A.
        • Carey R.B.
        • et al.
        Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
        Clin Microbiol Infect. 2012; 18: 268-281
        • Liu C.
        • Bayer A.
        • Cosgrove S.E.
        • et al.
        Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
        Clin Infect Dis. 2011; 52: e18-e55
        • Havey T.C.
        • Fowler R.A.
        • Daneman N.
        Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis.
        Crit Care. 2011; 15: R267
        • Spellberg B.
        The maturing antibiotic mantra: ʻʻshorter is still betterʼʼ.
        J Hosp Med. 2018; 13: 361-362
        • Royer S.
        • DeMerle K.M.
        • Dickson R.P.
        • Prescott H.C.
        Shorter versus longer courses of antibiotics for infection in hospitalized patients: a systematic review and meta-analysis.
        J Hosp Med. 2018; 13: 336-342
        • Uranga A.
        • Espana P.P.
        • Bilbao A.
        • et al.
        Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial.
        JAMA Intern Med. 2016; 176: 1257-1265
        • Llor C.
        • Bjerrum L.
        Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.
        Ther Adv Drug Saf. 2014; 5: 229-241
        • Dingle K.E.
        • Didelot X.
        • Quan T.P.
        • et al.
        Effects of control interventions on Clostridium difficile infection in England: an observational study.
        Lancet Infect Dis. 2017; 17: 411-421
        • Drahos J.
        • Vanwormer J.J.
        • Greenlee R.T.
        • Landgren O.
        • Koshiol J.
        Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data.
        Ann Epidemiol. 2013; 23: 291-293
        • Mukhopadhyay A.
        • Maliapen M.
        • Ong V.
        • et al.
        Community-acquired pneumonia case validation in an anonymized electronic medicalrecord-linked expert system.
        Clin Infect Dis. 2017; 64: S141-S144
        • Ruhe J.J.
        • Hasbun R.
        Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance.
        Clin Infect Dis. 2003; 36: 1132-1138